These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 27576883)
1. Prognostic Significance of Blood Type A in Patients with Renal Cell Carcinoma. Ko K; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C Urol J; 2016 Aug; 13(4):2765-72. PubMed ID: 27576883 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of ABO blood group in patients with renal cell carcinoma: single-institution results from a large cohort. Lee C; You D; Sohn M; Jeong IG; Song C; Kwon T; Hong B; Hong JH; Ahn H; Kim CS J Cancer Res Clin Oncol; 2015 Aug; 141(8):1441-7. PubMed ID: 25687379 [TBL] [Abstract][Full Text] [Related]
3. ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma. Kaffenberger SD; Morgan TM; Stratton KL; Boachie AM; Barocas DA; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE BJU Int; 2012 Dec; 110(11 Pt B):E641-6. PubMed ID: 22958439 [TBL] [Abstract][Full Text] [Related]
4. A Novel Predictor of Survival with Renal Cell Carcinoma After Nephrectomy. Peng D; He ZS; Li XS; Tang Q; Zhang L; Yang KW; Yu XT; Zhang CJ; Zhou LQ J Endourol; 2017 Apr; 31(4):397-404. PubMed ID: 28121179 [TBL] [Abstract][Full Text] [Related]
5. Survival analysis of surgically treated renal cell carcinoma: a single Chinese medical center experience from 2002 to 2012. Zhang Y; Yu H; Li H Int Urol Nephrol; 2015 Aug; 47(8):1327-33. PubMed ID: 26163269 [TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up. Barth DA; Sareban N; Lindner AK; Daller LAJ; Matzhold EM; Hutterer G; Smolle M; Mischinger J; Riedl JM; Seles M; Mannweiler S; Bauernhofer T; Pummer K; Pichler R; Zigeuner R; Schlenke P; Pichler M Urol Oncol; 2021 Oct; 39(10):736.e9-736.e16. PubMed ID: 34247906 [TBL] [Abstract][Full Text] [Related]
7. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study. Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065 [TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy. Moreira DM; Gershman B; Lohse CM; Boorjian SA; Cheville JC; Leibovich BC; Thompson RH World J Urol; 2016 Oct; 34(10):1465-72. PubMed ID: 26914818 [TBL] [Abstract][Full Text] [Related]
10. External validation of the updated Leibovich prognostic models for clear cell and papillary renal cell carcinoma in an Asian population. Lee HJ; Lee A; Huang HH; Lau WKO Urol Oncol; 2019 Jun; 37(6):356.e9-356.e18. PubMed ID: 30905510 [TBL] [Abstract][Full Text] [Related]
11. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ; BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519 [TBL] [Abstract][Full Text] [Related]
12. Pre-existing type 2 diabetes is an adverse prognostic factor in patients with renal cell carcinoma. Yang H; Yin K; Wang Y; Xia M; Zhang R; Wang W; Chen J; Wang C; Shuang W J Diabetes; 2019 Dec; 11(12):993-1001. PubMed ID: 31141620 [TBL] [Abstract][Full Text] [Related]
13. Preoperative serum cholesterol is an independent prognostic factor for patients with renal cell carcinoma (RCC). de Martino M; Leitner CV; Seemann C; Hofbauer SL; Lucca I; Haitel A; Shariat SF; Klatte T BJU Int; 2015 Mar; 115(3):397-404. PubMed ID: 24698164 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of modified Glasgow Prognostic Score in patients with non-metastatic clear cell renal cell carcinoma. Cho DS; Kim SI; Choo SH; Jang SH; Ahn HS; Kim SJ Scand J Urol; 2016 Jun; 50(3):186-91. PubMed ID: 26878156 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Preoperative Prognostic Nutritional Index in Patients Undergoing Nephrectomy for Nonmetastatic Renal Cell Carcinoma. Kim SJ; Kim SI; Cho DS Am J Clin Oncol; 2020 Jun; 43(6):388-392. PubMed ID: 32079852 [TBL] [Abstract][Full Text] [Related]
16. The Relationship Between Red Cell Distribution Width and Cancer-Specific Survival in Patients With Renal Cell Carcinoma Treated With Partial and Radical Nephrectomy. Życzkowski M; Rajwa P; Gabrys E; Jakubowska K; Jantos E; Paradysz A Clin Genitourin Cancer; 2018 Jun; 16(3):e677-e683. PubMed ID: 29339043 [TBL] [Abstract][Full Text] [Related]
17. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma. Tosco L; Van Poppel H; Frea B; Gregoraci G; Joniau S Eur Urol; 2013 Apr; 63(4):646-52. PubMed ID: 23041360 [TBL] [Abstract][Full Text] [Related]
18. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy. Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308 [TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma. Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555 [TBL] [Abstract][Full Text] [Related]
20. Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma. Nakayama T; Saito K; Kumagai J; Nakajima Y; Kijima T; Yoshida S; Kihara K; Fujii Y Clin Genitourin Cancer; 2018 Dec; 16(6):e1151-e1158. PubMed ID: 30213543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]